EGFR-Targeting Monoclonal Antibodies in Head and Neck Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|6|8|691-710

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.6, Iss.8, 2006-12, pp. : 691-710

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

EGFR-Targeting Monoclonal Antibodies in Head and Neck Cancer

By  

Current Cancer Drug Targets, Vol. 7, Iss. 7, 2007-11 ,pp. : 650-665

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Angiogenesis in Head and Neck Cancer

By  

Current Cancer Drug Targets, Vol. 7, Iss. 7, 2007-11 ,pp. : 643-649

Bentham Science Publishers

Access to resources Recommend Favorite

EGFR-targeting agents in oncology

By Garofalo Sonia   Rosa Roberta   Bianco Roberto   Tortora Giampaolo  

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 8, 2008-08 ,pp. : 889-901

Informa Healthcare

Access to resources Recommend Favorite

EGFR targeting drugs in the treatment of head and neck squamous cell carcinoma

By Sundvall Maria   Karrila Anna   Nordberg Janne   Grénman Reidar   Elenius Klaus  

Expert Opinion on Emerging Drugs, Vol. 15, Iss. 2, 2010-06 ,pp. : 185-201

Informa Healthcare

Access to resources Recommend Favorite

Role of EGFR Monoclonal Antibodies in the Management of Non–small Cell Lung Cancer

By  

Current Cancer Drug Targets, Vol. 15, Iss. 9, 2015-11 ,pp. : 792-802

Bentham Science Publishers

Access to resources Recommend Favorite